Prosecution Insights
Last updated: May 29, 2026

Examiner: KOSAR, AARON J

Tech Center 1600 • Art Units: 1651 1655 1657

This examiner grants 71% of resolved cases

Performance Statistics

71.0%
Allow Rate
+11.0% vs TC avg
787
Total Applications
+30.2%
Interview Lift
1260
Avg Prosecution Days
Based on 773 resolved cases, 2023–2026

Rejection Statute Breakdown

3.5%
§101 Eligibility
11.4%
§102 Novelty
48.2%
§103 Obviousness
14.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18302111 SYSTEMS AND METHODS FOR EX VIVO PERFUSION OF VERTEBRATE TISSUE Non-Final OA THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
18389152 CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE Non-Final OA R.J. REYNOLDS TOBACCO COMPANY
18502985 CHEMICAL MITIGATION OF AFRICAN SWINE FEVER VIRUS AND CLASSICAL SWINE FEVER VIRUS Non-Final OA Kansas State University Research Foundation
18364562 DECELLULARIZED HEART VALVE (DHV) COMPOSITE, AND PREPARATION METHOD AND USE THEREOF Non-Final OA UNION HOSPITAL TONGJI MEDICAL COLLEGE HUST
18335561 SOFT, CHEWABLE AND ORALLY DISSOLVABLE AND/OR DISINTEGRABLE PRODUCTS Non-Final OA Philip Morris USA Inc.
17906602 DEVICE FOR PERFUSION AND PRESERVATION OF TISSUE SPECIMENS EX VIVO Non-Final OA IMPERIAL COLLEGE INNOVATIONS LIMITED
17605845 ANTHOCYANIN EXTRACTION METHODS Non-Final OA WiSys Technology Foundation, Inc.
18029316 APPARATUS AND METHODS FOR CONTROLLING ORGAN TEMPERATURE PRIOR TO AND/OR DURING TRANSPLANTATION PROCEDURES Non-Final OA THE UNIVERSITY OF SASKATCHEWAN

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month